Published in BMC Health Serv Res on April 19, 2006
The cost-effectiveness of telestroke in the treatment of acute ischemic stroke. Neurology (2011) 2.62
Cost-effectiveness analysis of screening for KRAS and BRAF mutations in metastatic colorectal cancer. J Natl Cancer Inst (2012) 2.52
Cost-effectiveness of cytochrome P450 2C19 genotype screening for selection of antiplatelet therapy with clopidogrel or prasugrel. Pharmacotherapy (2012) 2.49
Using the net benefit regression framework to construct cost-effectiveness acceptability curves: an example using data from a trial of external loop recorders versus Holter monitoring for ambulatory monitoring of "community acquired" syncope. BMC Health Serv Res (2006) 1.58
Economic evaluation of a task-shifting intervention for common mental disorders in India. Bull World Health Organ (2012) 1.31
Cost effectiveness of seasonal intermittent preventive treatment using amodiaquine & artesunate or sulphadoxine-pyrimethamine in Ghanaian children. PLoS One (2010) 1.28
The Irritable Bowel Syndrome Outcome Study (IBSOS): rationale and design of a randomized, placebo-controlled trial with 12 month follow up of self- versus clinician-administered CBT for moderate to severe irritable bowel syndrome. Contemp Clin Trials (2012) 1.05
Cost and cost-effectiveness of the COMBINE study in alcohol-dependent patients. Arch Gen Psychiatry (2008) 1.00
Efficacy and cost-effectiveness of a physiotherapy program for chronic rotator cuff pathology: a protocol for a randomised, double-blind, placebo-controlled trial. BMC Musculoskelet Disord (2007) 0.99
Ticagrelor versus genotype-driven antiplatelet therapy for secondary prevention after acute coronary syndrome: a cost-effectiveness analysis. Value Health (2011) 0.88
Effects of laterally wedged insoles on symptoms and disease progression in medial knee osteoarthritis: a protocol for a randomised, double-blind, placebo controlled trial. BMC Musculoskelet Disord (2007) 0.87
Economic impact of minimally invasive lumbar surgery. World J Orthop (2015) 0.86
Cost-effectiveness analysis of endovascular versus neurosurgical treatment for ruptured intracranial aneurysms in the United States. J Neurosurg (2009) 0.85
Economic evaluation of a lifestyle intervention in primary care to prevent type 2 diabetes mellitus and cardiovascular diseases: a randomized controlled trial. BMC Fam Pract (2013) 0.85
Revisiting the cost-effectiveness of the COMBINE study for alcohol dependent patients: the patient perspective. Med Care (2010) 0.85
Cost-effectiveness of minimally invasive sacroiliac joint fusion. Clinicoecon Outcomes Res (2015) 0.84
Addition of telephone coaching to a physiotherapist-delivered physical activity program in people with knee osteoarthritis: a randomised controlled trial protocol. BMC Musculoskelet Disord (2012) 0.83
Trial-based economic evaluations in occupational health: principles, methods, and recommendations. J Occup Environ Med (2014) 0.82
Cost-effectiveness analysis: a proposal of new reporting standards in statistical analysis. J Biopharm Stat (2014) 0.81
Nurse-led follow-up of patients after oesophageal or gastric cardia cancer surgery: a randomised trial. Br J Cancer (2008) 0.79
Working on wellness (WOW): a worksite health promotion intervention programme. BMC Public Health (2012) 0.78
Methodologies used in cost-effectiveness models for evaluating treatments in major depressive disorder: a systematic review. Cost Eff Resour Alloc (2012) 0.78
Economic evaluation of treating clinically isolated syndrome and subsequent multiple sclerosis with interferon beta-1b. Neurol Sci (2009) 0.78
A physiotherapist-delivered integrated exercise and pain coping skills training intervention for individuals with knee osteoarthritis: a randomised controlled trial protocol. BMC Musculoskelet Disord (2012) 0.78
A Cost-Effectiveness Analysis of the Swedish Universal Parenting Program All Children in Focus. PLoS One (2015) 0.77
Practice network-based care management for patients with type 2 diabetes and multiple comorbidities (GEDIMAplus): study protocol for a randomized controlled trial. Trials (2014) 0.77
Computed tomography screening for lung cancer in the National Lung Screening Trial: a cost-effectiveness analysis. J Thorac Imaging (2015) 0.77
High-sensitive troponin T assay for the diagnosis of acute myocardial infarction: an economic evaluation. BMC Cardiovasc Disord (2014) 0.76
Protocol for an economic evaluation alongside the University Health Network Whiplash Intervention Trial: cost-effectiveness of education and activation, a rehabilitation program, and the legislated standard of care for acute whiplash injury in Ontario. BMC Public Health (2011) 0.75
Dose-response of spinal manipulation for cervicogenic headache: study protocol for a randomized controlled trial. Chiropr Man Therap (2016) 0.75
Cost-effectiveness analysis of whole-mount pathology processing for patients with early breast cancer undergoing breast conservation. Curr Oncol (2016) 0.75
Cost-effectiveness of adalimumab for rheumatoid arthritis in Germany. Z Rheumatol (2016) 0.75
Cost-effectiveness Assessment of Cardiac Interventions: Determining a Socially Acceptable Cost Threshold. Interv Cardiol (Lond) (2015) 0.75
Cost-effectiveness comparison of response strategies to a large-scale anthrax attack on the chicago metropolitan area: impact of timing and surge capacity. Biosecur Bioterror (2012) 0.75
Cost-effectiveness of nurse-led multifactorial care to prevent or postpone new disabilities in community-living older people: Results of a cluster randomized trial. PLoS One (2017) 0.75
Cost-effectiveness analysis of quadrivalent versus trivalent influenza vaccine in Taiwan: A lifetime multi-cohort model. Hum Vaccin Immunother (2016) 0.75
Cost-effectiveness of community versus hospital eye service follow-up for patients with quiescent treated age-related macular degeneration alongside the ECHoES randomised trial. BMJ Open (2016) 0.75
Cost-effectiveness of steroid (methylprednisolone) injections versus anaesthetic alone for the treatment of Morton's neuroma: economic evaluation alongside a randomised controlled trial (MortISE trial). J Foot Ankle Res (2015) 0.75
Cost-effectiveness of extended release naltrexone to prevent relapse among criminal justice-involved individuals with a history of opioid use disorder. Addiction (2017) 0.75
A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med (2002) 16.31
Costs, effects and C/E-ratios alongside a clinical trial. Health Econ (1995) 6.63
Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Econ (2001) 6.48
Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis. Med Decis Making (1998) 5.14
Cost-effectiveness acceptability curves--facts, fallacies and frequently asked questions. Health Econ (2004) 4.92
Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Econ (1997) 4.43
Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane. Health Econ (1998) 2.96
The CE plane: a graphic representation of cost-effectiveness. Med Decis Making (1990) 2.93
An economic evaluation of activated protein C treatment for severe sepsis. N Engl J Med (2002) 2.69
Handling uncertainty when performing economic evaluation of healthcare interventions. Health Technol Assess (1999) 2.63
Definition, interpretation and calculation of cost-effectiveness acceptability curves. Health Econ (2000) 2.27
Cost effectiveness of initial endoscopy for dyspepsia in patients over age 50 years: a randomised controlled trial in primary care. Lancet (2000) 1.83
Cost effectiveness of lung-volume-reduction surgery for patients with severe emphysema. N Engl J Med (2003) 1.79
Problems with interval estimates of the incremental cost-effectiveness ratio. Med Decis Making (1999) 1.63
Confidence intervals for cost-effectiveness ratios: an application of Fieller's theorem. Health Econ (1997) 1.55
Analysis of uncertainty in health care cost-effectiveness studies: an introduction to statistical issues and methods. Stat Methods Med Res (2002) 1.52
Cost-effectiveness of rhythm versus rate control in atrial fibrillation. Ann Intern Med (2004) 1.52
Cost-effectiveness of brief cognitive behaviour therapy versus treatment as usual in recurrent deliberate self-harm: a decision-making approach. Psychol Med (2003) 1.35
Inference for the cost-effectiveness acceptability curve and cost-effectiveness ratio. Pharmacoeconomics (2000) 1.27
Effect of clinical risk stratification on cost-effectiveness of the implantable cardioverter-defibrillator: the Canadian implantable defibrillator study. Circulation (2001) 0.91
To be or not to be in normal sinus rhythm: what do we really know? Ann Intern Med (2004) 0.88
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98
Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79
Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02
Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation (2009) 27.89
Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2007) 22.81
Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation (2014) 22.74
Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2006) 19.43
Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2008) 15.35
Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation (2011) 14.00
Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation (2010) 13.28
Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2009) 12.34
Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2015) 10.14
Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation (2010) 9.18
Delayed time to defibrillation after in-hospital cardiac arrest. N Engl J Med (2008) 8.36
Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med (2010) 8.28
The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet (2006) 7.17
Cardiopulmonary resuscitation of adults in the hospital: a report of 14720 cardiac arrests from the National Registry of Cardiopulmonary Resuscitation. Resuscitation (2003) 6.95
Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2014) 6.55
Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2012) 6.24
First documented rhythm and clinical outcome from in-hospital cardiac arrest among children and adults. JAMA (2006) 6.23
Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2013) 6.13
Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail (2013) 4.98
Incidence of treated cardiac arrest in hospitalized patients in the United States. Crit Care Med (2011) 4.43
Advanced cardiac life support in out-of-hospital cardiac arrest. N Engl J Med (2004) 4.09
Rationale, development and implementation of the Resuscitation Outcomes Consortium Epistry-Cardiac Arrest. Resuscitation (2008) 3.98
Emergency medical services intervals and survival in trauma: assessment of the "golden hour" in a North American prospective cohort. Ann Emerg Med (2009) 3.92
A trial of an impedance threshold device in out-of-hospital cardiac arrest. N Engl J Med (2011) 3.76
Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic. J Infect Dis (2008) 3.38
Hospital variation in time to defibrillation after in-hospital cardiac arrest. Arch Intern Med (2009) 3.27
Executive Summary: Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2016) 2.87
Chest compression rates and survival following out-of-hospital cardiac arrest. Crit Care Med (2015) 2.77
Racial differences in survival after in-hospital cardiac arrest. JAMA (2009) 2.65
Clinical practice patterns and cost effectiveness of human epidermal growth receptor 2 testing strategies in breast cancer patients. Cancer (2009) 2.63
F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2). J Am Coll Cardiol (2007) 2.50
Early versus later rhythm analysis in patients with out-of-hospital cardiac arrest. N Engl J Med (2011) 2.45
What is the role of chest compression depth during out-of-hospital cardiac arrest resuscitation?. Crit Care Med (2012) 2.44
Appropriate cardiac cath lab activation: optimizing electrocardiogram interpretation and clinical decision-making for acute ST-elevation myocardial infarction. Am Heart J (2010) 2.33
Survival after application of automatic external defibrillators before arrival of the emergency medical system: evaluation in the resuscitation outcomes consortium population of 21 million. J Am Coll Cardiol (2010) 2.29
Relationship between chest compression rates and outcomes from cardiac arrest. Circulation (2012) 2.25
Effect of real-time feedback during cardiopulmonary resuscitation outside hospital: prospective, cluster-randomised trial. BMJ (2011) 2.22
Expanding access to HAART: a cost-effective approach for treating and preventing HIV. AIDS (2010) 2.04
The impact of increased chest compression fraction on return of spontaneous circulation for out-of-hospital cardiac arrest patients not in ventricular fibrillation. Resuscitation (2011) 1.98
Self-reported Morisky score for identifying nonadherence with cardiovascular medications. Ann Pharmacother (2004) 1.96
Regional systems of care for out-of-hospital cardiac arrest: A policy statement from the American Heart Association. Circulation (2010) 1.80
Predicting survival after out-of-hospital cardiac arrest: role of the Utstein data elements. Ann Emerg Med (2009) 1.77
Adverse drug events associated with the antidotes for methanol and ethylene glycol poisoning: a comparison of ethanol and fomepizole. Ann Emerg Med (2008) 1.72
Impact of prehospital mode of transport after severe injury: a multicenter evaluation from the Resuscitation Outcomes Consortium. J Trauma Acute Care Surg (2012) 1.71
Positron emission tomography and recovery following revascularization (PARR-1): the importance of scar and the development of a prediction rule for the degree of recovery of left ventricular function. J Am Coll Cardiol (2002) 1.68
The cost-effectiveness of screening for colorectal cancer. CMAJ (2010) 1.67
Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial. JACC Cardiovasc Imaging (2009) 1.63
Survival increases with CPR by Emergency Medical Services before defibrillation of out-of-hospital ventricular fibrillation or ventricular tachycardia: observations from the Resuscitation Outcomes Consortium. Resuscitation (2009) 1.62
18F-FDG PET imaging of myocardial viability in an experienced center with access to 18F-FDG and integration with clinical management teams: the Ottawa-FIVE substudy of the PARR 2 trial. J Nucl Med (2010) 1.56
Active surface cooling protocol to induce mild therapeutic hypothermia after out-of-hospital cardiac arrest: a retrospective before-and-after comparison in a single hospital. Crit Care Med (2009) 1.54
Cost-effectiveness of rhythm versus rate control in atrial fibrillation. Ann Intern Med (2004) 1.52
Determinants of hospital length of stay among patients with pneumonia admitted to a large Canadian hospital from 1991 to 2001. Can Respir J (2005) 1.52
Continuous improvements in "chain of survival" increased survival after out-of-hospital cardiac arrests: a large-scale population-based study. Circulation (2009) 1.51
Receiving hospital characteristics associated with survival after out-of-hospital cardiac arrest. Resuscitation (2010) 1.48
Comparison of the Cerebral Performance Category score and the Health Utilities Index for survivors of cardiac arrest. Ann Emerg Med (2008) 1.45
Impact of reference-based pricing for histamine-2 receptor antagonists and restricted access for proton pump inhibitors in British Columbia. CMAJ (2002) 1.43
Resuscitation Outcomes Consortium (ROC) PRIMED cardiac arrest trial methods part 1: rationale and methodology for the impedance threshold device (ITD) protocol. Resuscitation (2008) 1.43
The effect of waiting time on pain intensity after elective surgical lumbar discectomy. Spine J (2013) 1.42
Does FDG PET-assisted management of patients with left ventricular dysfunction improve quality of life? A substudy of the PARR-2 trial. Can J Cardiol (2011) 1.37
Therapies for treatment of osteoporosis in US women: cost-effectiveness and budget impact considerations. Am J Manag Care (2008) 1.30
Effectiveness of a 30-min CPR self-instruction program for lay responders: a controlled randomized study. Resuscitation (2005) 1.28
Retention of CPR skills learned in a traditional AHA Heartsaver course versus 30-min video self-training: a controlled randomized study. Resuscitation (2007) 1.25
The value of implementation and the value of information: combined and uneven development. Med Decis Making (2008) 1.25
Discordant indigenous and provider frames explain challenges in improving access to arthritis care: a qualitative study using constructivist grounded theory. Int J Equity Health (2014) 1.23
Association Between Incretin-Based Drugs and the Risk of Acute Pancreatitis. JAMA Intern Med (2016) 1.21
Health-related quality of life is better for cardiac arrest survivors who received citizen cardiopulmonary resuscitation. Circulation (2003) 1.20
Effect of number of medications on cardiovascular therapy adherence. Ann Pharmacother (2002) 1.19
How does cost matter in health-care discrete-choice experiments? Health Econ (2011) 1.15
Increased risk of cardiovascular and cerebrovascular diseases in individuals with ankylosing spondylitis: a population-based study. Arthritis Rheum (2011) 1.14
Summary of NIH Medical-Surgical Emergency Research Roundtable held on April 30 to May 1, 2009. Ann Emerg Med (2010) 1.14
The American Heart Association's recommendations for expanding the applications of existing and future clinical registries: a policy statement from the American Heart Association. Circulation (2011) 1.14
The Alberta Hip and Knee Replacement Project: a model for health technology assessment based on comparative effectiveness of clinical pathways. Int J Technol Assess Health Care (2009) 1.13
Psychological distress and cancer survival: a follow-up 10 years after diagnosis. Psychosom Med (2003) 1.13
A sensitivity analysis using information about measured confounders yielded improved uncertainty assessments for unmeasured confounding. J Clin Epidemiol (2007) 1.11
Hospitalization costs of primary stenting versus thrombolysis in acute myocardial infarction: cost analysis of the Canadian STAT Study. Circulation (2003) 1.08
Personal privacy and public health: potential impacts of privacy legislation on health research in Canada. Can J Public Health (2008) 1.08
Elevated risk of asthma after hospitalization for respiratory syncytial virus infection in infancy. Paediatr Respir Rev (2013) 1.05
Antiretroviral resistance among HIV-infected persons who have died in British Columbia, in the era of modern antiretroviral therapy. J Infect Dis (2004) 1.04
Severe traumatic injury: regional variation in incidence and outcome. Ann Surg (2010) 1.01
The epidemiologic burden of hepatitis C virus infection in Latin America . Ann Hepatol (2012) 1.00
Variability in case-mix adjusted in-hospital cardiac arrest rates. Med Care (2012) 1.00
A crowdsourcing innovation challenge to locate and map automated external defibrillators. Circ Cardiovasc Qual Outcomes (2013) 0.99
Acute rejection and chronic nephropathy: a systematic review of the literature. Transplantation (2009) 0.99
Decreasing incidence of inflammatory bowel disease in eastern Canada: a population database study. BMC Gastroenterol (2014) 0.97
Development of canadian safety indicators for medication use. Healthc Q (2008) 0.97
Nonadherence increases the risk of hospitalization among HIV-infected antiretroviral naive patients started on HAART. J Int Assoc Physicians AIDS Care (Chic) (2008) 0.96